ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0870

Blood Brain Barrier Integrity and Brain Imaging Patterns in Patients with SLE

Shiran Aharon1, Dafna Ben-Bashat2, Orna Aizenstein3, Moran Artzi4, Mark Berman5, Victoria Furer6, Marina Anouk7, Yael Lahat8, Jonathan Wollman9, Ofir Elalouf9, Ari Polachek10 and Daphna Paran11, 1Wohl Institute of Advanced Imaging, Tel-Aviv Sourasky Medical Center, Sagol School of Neuroscience, Sackler Faculty of Medicine, Tel-Aviv, Israel, 2Wohl Institute of Advanced Imaging, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel, 3Department of Neuroradiology Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel, 4Wohl Institute of Advanced Imaging, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, 5Department of Rheumatology , Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel, 6Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 7Department of Rheumatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel, 8Department of Rheumatology , Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel, 9Tel Aviv Medical Center, Herzliya, Israel, 10Sourasky Medical Center, Petah-Tikva, Israel, 11Tel Aviv Sourasky Medical Center-Ichilov Hospital, Even Yehuda, Israel

Meeting: ACR Convergence 2021

Keywords: Brain, Neuroimaging, none, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: The pathogenesis of neuropsychiatric SLE (NPSLE) has not been fully elucidated. Recent evidence suggests impaired blood brain barrier (BBB) integrity as a possible mechanism leading to neuropsychiatric damage. We aimed to assess brain imaging patterns in patients with SLE, NPSLE and healthy controls utilizing multi-parametric MRI methods to assess cerebral atrophy, tissue and BBB integrity. We also aimed to assess correlations between imaging findings, clinical characteristics and cognition.

Methods: Twenty-three consecutive patients attending the Lupus clinic (NPSLE n=11, non-NPSLE n=12), and 20 age and gender matched healthy subjects were recruited. The MRI protocol included high-resolution T1 sequence (MP2RAGE), diffusion tensor imaging and dynamic contrast enhanced imaging utilizing a 3-Tesla MRI scanner. Brain segmentation was performed to assess volumetric changes, tissue integrity and BBB permeability in various brain regions. Clinical parameters, quality of life and cognition were assessed. Patients were divided into subgroups based on presence of NPSLE, SLE disease activity, disease duration, accrued damage and presence of antiphospholipid antibodies (aPL). Comparisons were performed between the entire patient group and the control group and between subgroups.

Results: The NPSLE group was significantly younger than the non-NPSLE group and significantly less educated compared to the healthy controls and the non-NPSLE group. The NPSLE group had significantly shorter disease duration, more accrued damage, more hypertension compared to the non-NPSLE group and a higher percentage were treated with anticoagulants.

Abnormal findings on conventional MRI (cMRI) were seen in 67% of the non-NPSLE group and 82% of the NPSLE group. Brain atrophy was seen in 43% of the patients and was not limited to NPSLE. In the NPSLE group a negative correlation was observed between the volume of grey matter and disease duration. The grey matter volume was significantly reduced in the NPSLE group and in patients with aPL as compared to healthy controls. The volume of the nucleus accumbens was significantly reduced in patients with a damage index of < 1 as compared to those without damage and compared to healthy controls. Impairment of BBB integrity, as expressed by increased permeability values compared to healthy controls was seen in 5 of the SLE patients (25%), 3 of whom were non-NPSLE. Increased permeability was detected in several cerebral grey and white matter regions. All 5 patients had significantly longer disease duration ( >10years) and as a group had a smaller volume of the anterior segment of the corpus callosum. One patient with SLE underwent MRI scanning during active disease and repeat scan when the disease was better controlled showing a reduction in BBB permeability by 25% in 8 brain regions.

Conclusion: In the present study we detected abnormal cMRI findings, brain atrophy and impaired BBB integrity among patients with SLE, which was not limited to patients with NPSLE. Our results suggest that impairment of the BBB occurs in patients with long disease duration and possibly during active disease, even in patients with SLE without overt NPSLE.


Disclosures: S. Aharon, None; D. Ben-Bashat, None; O. Aizenstein, None; M. Artzi, None; M. Berman, None; V. Furer, None; M. Anouk, None; Y. Lahat, None; J. Wollman, None; O. Elalouf, None; A. Polachek, None; D. Paran, None.

To cite this abstract in AMA style:

Aharon S, Ben-Bashat D, Aizenstein O, Artzi M, Berman M, Furer V, Anouk M, Lahat Y, Wollman J, Elalouf O, Polachek A, Paran D. Blood Brain Barrier Integrity and Brain Imaging Patterns in Patients with SLE [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/blood-brain-barrier-integrity-and-brain-imaging-patterns-in-patients-with-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/blood-brain-barrier-integrity-and-brain-imaging-patterns-in-patients-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology